Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 6c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Merit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2019, Gives FY 2020 Guidance
February 24, 2020 4:04 PM ESTQ4 2019 worldwide revenue of $257.9 million, up 10.6% as reported over Q4 2018Q4 2019 core revenue on a comparable, constant currency basis* up 8.5% over Q4 2018Q4 2019 GAAP loss per share was $(0.08), compared to GAAP EPS of $0.16 in Q4 2018Q4 2019 non-GAAP EPS* was $0.40, compared to $0.48 in Q4 2018
*Â Â Â Â Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin and non-GAAP gross margin are non-GAAP financial measures. A reconciliation of these and other non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures is included under the heading... More
